Alpine Woods Capital Investors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Alpine Woods Capital Investors’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-20,000	Closed	-$332K	–	514
2015 Q3	$332K	Hold	20,000	–	–	0.02%	384
2015 Q2	$450K	Buy	+20,000	New	+$493K	0.02%	331

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHM

Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alpine Woods Capital Investors's OMED Position: Q4 2015 in Review

Alpine Woods Capital Investors sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q4 2015, closing a stake of 20,000 shares — an estimated $332K sold.

Alpine Woods Capital Investors first reported a position in OMED in Q2 2015 and held it in 2 quarters. The position peaked at $450K in Q2 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q4 2015.

Alpine Woods Capital Investors reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Alpine Woods Capital Investors sold 20,000 OncoMed Pharmaceuticals, Inc. shares in Q4 2015, an estimated $332K.
Alpine Woods Capital Investors first reported a position in OncoMed Pharmaceuticals, Inc. in Q2 2015 and held it in 2 quarters.
Alpine Woods Capital Investors's OncoMed Pharmaceuticals, Inc. position peaked at $450K in Q2 2015.
83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q4 2015.

Based on Alpine Woods Capital Investors's 13F filing for Q4 2015, filed 10 Feb 2016.